The Center of Excellence is usually awarded to physicians and treatment centers that have a high degree of expertise in this world-leading technology while providing effective and lasting treatment for men suffering from benign prostatic hyperplasia.
Dr. Khalid Al Rumaihi is one of the first doctors and pioneers in the Middle East and North Africa to use Rezum as a non-invasive procedure for patients suffering from enlarged prostate, having performed on more than 150 cases using this technique at the Urology Department of ACC.
HMC was designated as a Center of Excellence out of three centers only in the Middle East and North Africa region.
The Rezum Treatment is the latest technology to treat an enlarged prostate without surgery and has been approved and included in international regulations and recommendations as its the first of its kind in the world. Its approved by US Food and Drug Administration. The procedure takes from 5 to 10 minutes, and the patient can leave the hospital on the same day.
"This technique is very safe and helps patients who do not want traditional operations that require staying a few days in the hospital. Its also suitable for patients who do not want to use medical drugs permanently, as 90% of patients do not need to take prostate drugs after undergoing treatment with Rezum technology," Dr. Al Rumaihi said
Boston Scientific, an American company that invented Rezum technology, and is one of the top 10 medical companies worldwide, it is a leader in creating minimally invasive medical procedures that help patients around the world, and the healthcare providers with the challenges that they usually face and works in collaboration with healthcare professionals to develop the most effective solutions for the patient.
